The Role of Vitamin D in Patients with Otitis Media with Effusion

akcan, fatih; Ozergin Coskun, Zerrin; DUNDAR, YUSUF; DURSUN, Engin; Demirbaş, Erol; Birinci, Mehmet; Tımurkaynak, Yasemın

doi:10.24179/kbbbbc.2017-56598

The Role of Vitamin D in Patients with Otitis Media with Effusion

Yusuf DÜNDAR, (Rize Devlet Hastanesi, Kulak Burun Boğaz Kliniği,Rize,Türkiye)

Yasemin TİMURKAYNAK, (Rize Devlet Hastanesi, Kulak Burun Boğaz Kliniği,Rize,Türkiye)

Erol DEMİRBAŞ, (Rize Devlet Hastanesi, Kulak Burun Boğaz Kliniği,Rize,Türkiye)

Mehmet BİRİNCİ, (Recep Tayyip Erdoğan Üniversitesi ,Tıp Fakültesi ,Kulak Burun Boğaz Anabilim Dalı, Rize,Türkiye)

Zerrin ÖZERGİN, (Recep Tayyip Erdoğan Üniversitesi ,Tıp Fakültesi ,Kulak Burun Boğaz Anabilim Dalı, Rize,Türkiye)

Engin DURSUN, (Recep Tayyip Erdoğan Üniversitesi ,Tıp Fakültesi ,Kulak Burun Boğaz Anabilim Dalı, Rize,Türkiye)

Fatih AKCAN (Düzce Üniversitesi ,Tıp Fakültesi ,Kulak Burun Boğaz Anabilim Dalı, Düzce,Türkiye)

Kulak Burun Boğaz ve Baş Boyun Cerrahisi

3 0

Yıl: 2018 Cilt: 26 Sayı: 2 Sayfa Aralığı: 33 - 39 Metin Dili: İngilizce DOI: 10.24179/kbbbbc.2017-56598 İndeks Tarihi: 03-11-2020

The Role of Vitamin D in Patients with Otitis Media with Effusion

Öz:

Objective: Vitamin D has multiple functions other than calcium metabolism. How- ever, there exists a paucity of data to explain the role of Vitamin D deficiency in patients with otitis media with effusion (OME). Material and Methods: This retrospective review of OME with 320 patients was conducted from 2014 to 2016. The case files of patients with OME were analyzed retrospectively and patients were included in the study if 25(OH)D levels were avail- able. Physician documented visit records were identified and statistical analysis was performed by using SPSS version 21 (IBM, Armonk, NY). Results: Of the initial 320 patients with OME,67 patients had 25(OH)D levels available. 18 out of 67 patients were excluded from the study based on exclusion criteria further detailed in the study. A total of 30 boys (61.2%) and 19 girls (38.8%) were included with mean age 5.85±2.74 years. The mean 25OHVitaminD level was16.87. 18 of 49 patients had 25OHVitaminD deficiency (Group 1). 31 patients had 25OHVita- minD level ≥15 (Group 2). The mean duration of treatment was 6.83 weeks and 3.80 weeks in Group 1 and Group 2 respectively (p: 0.010). 8 of 18 patients (44.4%) in the Group 1 underwent ventilation tube insertion while 4 of 31 patients (12.9%) underwent ventilation tube insertionin the Group 2 (p: 0.018). There was no statistical significance between the subgroups address- ing to age, sex, primary symptom, history of smoking at home, type of house heating. Conclu- sion: There is a significant association between 25OHVitaminD deficiency and treatment outcomes of OME.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012;76(3):315-25.
2. Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M, et al. T-cell cytokines dif- ferentially control human monocyte antimicro- bial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A 2010;107(2):22593-8.
3. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009;94(1):26-34.
4. Hughes DA, Norton R. Vitamin D and respira- tory health. Clin Exp Immunol 2009;158(1):20- 5.
5. Walker VP, Modlin RL. The vitamin D connec- tion to pediatric infections and immune function. Pediatr Res 2009;65(5 Pt 2):106R-13R. 6. Cayir A, Turan MI, Ozkan O, Cayir Y. Vitamin D levels in children diagnosed with acute oti- tis media. J Pak Med Assoc 2014;64(11): 1274-7.
7. Bylander-Groth A, Stenström C. Eustachian tube function and otitis media in children. Ear Nose Throat J 1998;77(9):762-4.
8. Lee HJ, Park SK, Choi KY, Park SE, Chun YM, Kim KS, et al. Korean clinical practice guidelines: otitis media in children. J Korean Med Sci 2012;27(8):835-48.
9. Kirbas A, Kirbas S, Anlar O, Turkyilmaz AK, Cure MC, Efe H. Investigation of the rela- tionship between vitamin D and bone min- eral density in newly diagnosed multiple sclerosis. Acta Neurol Belg 2013;113(1):43- 7.
10. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al; IOF Committee of Scientific Advisors (CSA) Nutri- tion Working Group. Global vitamin D status and determinants of hypovitaminosis D. Os- teoporos Int 2009;20(11):1807-20.
11. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: reviewofcurrentknowledgeandrec- ommendations. Pediatrics 2008;122(2):398-417.
12. Selvaraj P. Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam Horm 2011;86:307-25.
13. Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008;68(3):261-9.
14. Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004;89-90(1-5):437-41.
15. Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihy- droxyvitamin D(3). J Cyst Fibros 2007;6(6): 403-10.
16. Dini C, Bianchi A. The potential role of vitamin D for prevention and treatment of tuberculosis and infectious diseases. Ann Ist Super Sanita 2012;48(3):319-27.
17. Ralph AP. Vitamin D supplementation in pa- tients with tuberculosis. Am Fam Physician 2010;82(6):577-83. 18. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic in- fluenza and vitamin D. Epidemiol Infect 2006;134(6):1129-40.
19. Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, el Beshry M, et al. Vitamin D adminis- tration to tuberculous children and its value. Boll Chim Farm 1998;137(5):157-64.
20. Cantorna MT, Zhao J, Yang L. Vitamin D, in- variant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc 2012;71(1):62-6.
21. Marom T, Marchisio P, Tamir SO, Torretta S, Gavriel H, Esposito S. Complementary and al- ternative medicine treatment options for otitis media: a systematic review. Medicine (Balti- more) 2016;95(6):e2695. 22. Levi JR, Brody RM, McKee-Cole K, Pribitkin E, O’Reilly R. Complementary and alternative medicine for pediatric otitis media. Int J Pedi- atr Otorhinolaryngol 2013;77(6):926-31.
23. Djurhuus BD, Skytthe A, Christensen K, Faber CE. Increasing rate of middle ear ventilation tube insertion in children in Denmark. Int J Pe- diatr Otorhinolaryngol 2014;78(9):1541-4.
24. Browning GG, Rovers MM, Williamson I, Lous J, Burton MJ. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 2010;6(10):CD001801.
25. Lubianca Neto JF, Hemb L, Silva DB. Sys- tematic literature review of modifiable risk fac- tors for recurrent acute otitis media in childhood. J Pediat (Rio J) 2006;82(2):87-96.

APA	DUNDAR Y, Tımurkaynak Y, Demirbaş E, Birinci M, Ozergin Coskun Z, DURSUN E, akcan f (2018). The Role of Vitamin D in Patients with Otitis Media with Effusion. , 33 - 39. 10.24179/kbbbbc.2017-56598
Chicago	DUNDAR YUSUF,Tımurkaynak Yasemın,Demirbaş Erol,Birinci Mehmet,Ozergin Coskun Zerrin,DURSUN Engin,akcan fatih The Role of Vitamin D in Patients with Otitis Media with Effusion. (2018): 33 - 39. 10.24179/kbbbbc.2017-56598
MLA	DUNDAR YUSUF,Tımurkaynak Yasemın,Demirbaş Erol,Birinci Mehmet,Ozergin Coskun Zerrin,DURSUN Engin,akcan fatih The Role of Vitamin D in Patients with Otitis Media with Effusion. , 2018, ss.33 - 39. 10.24179/kbbbbc.2017-56598
AMA	DUNDAR Y,Tımurkaynak Y,Demirbaş E,Birinci M,Ozergin Coskun Z,DURSUN E,akcan f The Role of Vitamin D in Patients with Otitis Media with Effusion. . 2018; 33 - 39. 10.24179/kbbbbc.2017-56598
Vancouver	DUNDAR Y,Tımurkaynak Y,Demirbaş E,Birinci M,Ozergin Coskun Z,DURSUN E,akcan f The Role of Vitamin D in Patients with Otitis Media with Effusion. . 2018; 33 - 39. 10.24179/kbbbbc.2017-56598
IEEE	DUNDAR Y,Tımurkaynak Y,Demirbaş E,Birinci M,Ozergin Coskun Z,DURSUN E,akcan f "The Role of Vitamin D in Patients with Otitis Media with Effusion." , ss.33 - 39, 2018. 10.24179/kbbbbc.2017-56598
ISNAD	DUNDAR, YUSUF vd. "The Role of Vitamin D in Patients with Otitis Media with Effusion". (2018), 33-39. https://doi.org/10.24179/kbbbbc.2017-56598

APA	DUNDAR Y, Tımurkaynak Y, Demirbaş E, Birinci M, Ozergin Coskun Z, DURSUN E, akcan f (2018). The Role of Vitamin D in Patients with Otitis Media with Effusion. Kulak Burun Boğaz ve Baş Boyun Cerrahisi, 26(2), 33 - 39. 10.24179/kbbbbc.2017-56598
Chicago	DUNDAR YUSUF,Tımurkaynak Yasemın,Demirbaş Erol,Birinci Mehmet,Ozergin Coskun Zerrin,DURSUN Engin,akcan fatih The Role of Vitamin D in Patients with Otitis Media with Effusion. Kulak Burun Boğaz ve Baş Boyun Cerrahisi 26, no.2 (2018): 33 - 39. 10.24179/kbbbbc.2017-56598
MLA	DUNDAR YUSUF,Tımurkaynak Yasemın,Demirbaş Erol,Birinci Mehmet,Ozergin Coskun Zerrin,DURSUN Engin,akcan fatih The Role of Vitamin D in Patients with Otitis Media with Effusion. Kulak Burun Boğaz ve Baş Boyun Cerrahisi, vol.26, no.2, 2018, ss.33 - 39. 10.24179/kbbbbc.2017-56598
AMA	DUNDAR Y,Tımurkaynak Y,Demirbaş E,Birinci M,Ozergin Coskun Z,DURSUN E,akcan f The Role of Vitamin D in Patients with Otitis Media with Effusion. Kulak Burun Boğaz ve Baş Boyun Cerrahisi. 2018; 26(2): 33 - 39. 10.24179/kbbbbc.2017-56598
Vancouver	DUNDAR Y,Tımurkaynak Y,Demirbaş E,Birinci M,Ozergin Coskun Z,DURSUN E,akcan f The Role of Vitamin D in Patients with Otitis Media with Effusion. Kulak Burun Boğaz ve Baş Boyun Cerrahisi. 2018; 26(2): 33 - 39. 10.24179/kbbbbc.2017-56598
IEEE	DUNDAR Y,Tımurkaynak Y,Demirbaş E,Birinci M,Ozergin Coskun Z,DURSUN E,akcan f "The Role of Vitamin D in Patients with Otitis Media with Effusion." Kulak Burun Boğaz ve Baş Boyun Cerrahisi, 26, ss.33 - 39, 2018. 10.24179/kbbbbc.2017-56598
ISNAD	DUNDAR, YUSUF vd. "The Role of Vitamin D in Patients with Otitis Media with Effusion". Kulak Burun Boğaz ve Baş Boyun Cerrahisi 26/2 (2018), 33-39. https://doi.org/10.24179/kbbbbc.2017-56598